Management

  • Rainer Lichtenberger, Ph.D. MBA
    CEO

    25 years management in life science Industry, EVP Merckle/ratiopharm group for BD; Since 12 years CEO/COO experience in several SME, raised € 35 Mn venture funds.

  • Christian Wallasch, Ph.D.
    COO

    Seasoned executive management member (COO, CEO) in biopharmaceuticals SME, as Axxima and U3, as well as public companies like Intercell/Valneva. Expert in kinase inhibitors, vaccines development, project management and execution.

  • Sebastian Canisius, MD, Ph.D.
    CMO

    MD with over 10 years experience in clinical development (principal investigator); expert in clinical development of respiratory / infectious diseases.

  • Prof. Oliver Planz, Ph.D.
    CSO

    Universität D-Tübingen,Co-inventor of the technology, expert in antiviral research und translational preclinical R&D up to clinical studies. Advises the WHO on antiviral strategies against influenza.

  • Henrik Luessen, Ph.D.
    CBO

    Serial entrepreneur/strategic consultant to SME life science companies. Track record of financing/trade sales of € 200 Mn, closing 200 licensing partnerships.

  • 1

Address

Atriva Therapeutics GmbH
Christophstr. 32, 72072 Tübingen

+49 (0)7071 8597673
info@atriva-therapeutics.com

In order to be able to design our website in the best possible way and to continuously improve it, we are using cookies. By continuing to use our website, you permit the use of cookies. More information can be found in our data protection rules.
Data Protection Rules I Agree